Women SHINE: Addressing Syndemics and HIV Among Women Through Tech-Based Peer Engagement (NCT05509959)
๐ฉบ Plain-English Summary (8th-Grade Level)
A two-arm RCT will be conducted to test the efficacy of Women SHINE, a web-based trauma-informed peer navigation-social support intervention (Figure 2). A total of 360 women living with HIV/AIDS (WLHA) with a history of adulthood interpersonal violence who have been prescribed ART but are non-adherent (\< 90% ART adherent in the last 4 weeks) will be enrolled in the study. WLHA will be randomized (1:1) into one of the following conditions: 1) Women SHINE intervention arm (n=180) or 2) Control arm (n=180). The Women SHINE intervention arm will receive a four-month intervention including peer navigator (PN) one-on-one sessions, phone/text-based check-ins, 7 psychoeducation weekly support group sessions (120 mins.) co-facilitated by a licensed therapist and PN, and access to a static website with resources for HIV care, interpersonal violence, trauma, mental health, and substance use. The control arm will receive one group session (60 mins.) on self-care and well-being and access to the aforementioned website with resources. Women will complete a video-based survey and mailed hair sample self-collection at baseline, 4-, 8-, and 12-months post-randomization, to evaluate improvements in ART adherence (Aim 1), emotion regulation, and PTSD symptoms (Aim 2). Investigators will examine the mediating effect of individual (retention in HIV care, coping self-efficacy, social support, ancillary support services use) and socio-structural (stigma, medical mistrust) mechanisms of change on the efficacy of Women SHINE (Aim 3).
Who can join: Review the eligibility criteria below.
Location: The Regents of the Univ. of Calif., U.C. San Diego โ La Jolla, California
Age range: 18 Years
๐งช Interventions in This Study
- Women SHINE (BEHAVIORAL)
- Control (BEHAVIORAL)
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (1 Sites)
- The Regents of the Univ. of Calif., U.C. San Diego โ La Jolla, California
๐ Contact the Study Coordinator
Phone: (858) 534-7979
Email: clcyr@health.ucsd.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in HIV/AIDS
- Optimizing Tobacco Use Treatment for PLWHA โ Chicago, Illinois
- Intervention for Virologic Suppression in Youth โ San Francisco, California
- ResIlience-based Stigma REdUction Program ("Rise-up") โ Columbia, South Carolina
- Effects of Semaglutide in HIV-Associated Lipohypertrophy โ Cleveland, Ohio
- Robot-Assisted Rehabilitation After HIV-Associated Stroke: Botswana โ Philadelphia, Pennsylvania
- The Dreamer Girls Project: Adaptation of SISTA/SIHLE for HIV/AIDS and Substance Abuse Prevention Among Black Adolescent Girls โ Paterson, New Jersey
Explore by condition: All HIV/AIDS clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.